JP2015529660A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529660A5
JP2015529660A5 JP2015525943A JP2015525943A JP2015529660A5 JP 2015529660 A5 JP2015529660 A5 JP 2015529660A5 JP 2015525943 A JP2015525943 A JP 2015525943A JP 2015525943 A JP2015525943 A JP 2015525943A JP 2015529660 A5 JP2015529660 A5 JP 2015529660A5
Authority
JP
Japan
Prior art keywords
group
compound
compound according
deuterated
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015525943A
Other languages
English (en)
Japanese (ja)
Other versions
JP6450678B2 (ja
JP2015529660A (ja
Filing date
Publication date
Priority claimed from GBGB1214169.3A external-priority patent/GB201214169D0/en
Application filed filed Critical
Publication of JP2015529660A publication Critical patent/JP2015529660A/ja
Publication of JP2015529660A5 publication Critical patent/JP2015529660A5/ja
Application granted granted Critical
Publication of JP6450678B2 publication Critical patent/JP6450678B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015525943A 2012-08-08 2013-08-07 新規な化合物およびその使用 Active JP6450678B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1214169.3A GB201214169D0 (en) 2012-08-08 2012-08-08 New compounds and uses thereof
GB1214169.3 2012-08-08
PCT/GB2013/052106 WO2014023956A1 (en) 2012-08-08 2013-08-07 New compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2015529660A JP2015529660A (ja) 2015-10-08
JP2015529660A5 true JP2015529660A5 (enExample) 2016-09-29
JP6450678B2 JP6450678B2 (ja) 2019-01-09

Family

ID=46935104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015525943A Active JP6450678B2 (ja) 2012-08-08 2013-08-07 新規な化合物およびその使用

Country Status (11)

Country Link
US (2) US10385009B2 (enExample)
EP (1) EP2882708B1 (enExample)
JP (1) JP6450678B2 (enExample)
CN (1) CN104837814B (enExample)
AU (1) AU2013301340B2 (enExample)
CA (1) CA2881324C (enExample)
DK (1) DK2882708T3 (enExample)
ES (1) ES2702573T3 (enExample)
GB (1) GB201214169D0 (enExample)
PL (1) PL2882708T3 (enExample)
WO (1) WO2014023956A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104897818A (zh) * 2015-06-19 2015-09-09 重庆医药高等专科学校 一种同时测定比卡鲁胺中6种有关物质的uplc方法
KR101988757B1 (ko) * 2017-12-19 2019-06-12 가톨릭대학교 산학협력단 1,2-디하이드록시-3-메틸안트라퀴논을 유효성분으로 하는 간암 예방 또는 치료용 조성물
JP7197203B2 (ja) * 2018-05-30 2022-12-27 国立大学法人大阪大学 ヒト血管の形成、構造または機能に影響を及ぼす物質のスクリーニング方法、およびヒト血管の製造方法
CN113368056A (zh) * 2021-04-29 2021-09-10 重庆医科大学 一种负载巴诺蒽醌的无载体纳米递送系统及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197249A (en) 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
SE445996B (sv) 1977-08-15 1986-08-04 American Cyanamid Co Nya atrakinonderivat
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
GB8923075D0 (en) * 1989-10-13 1989-11-29 Patterson Laurence H Anti-cancer compounds
JP3696884B2 (ja) * 1994-03-25 2005-09-21 アイソテクニカ、インコーポレーテッド ジュウテリウム化による薬物の効能の増強
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2288274A1 (en) * 1997-04-28 1998-11-05 University Of Vermont Regioisomeric benzothiopyranopyridines having antitumor activity
GB9813062D0 (en) * 1998-06-18 1998-08-19 Univ Wales Medicine An anthraquinone and its derivatives
US6376531B1 (en) * 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
EP1104760B1 (en) * 1999-12-03 2003-03-12 Pfizer Products Inc. Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
MXPA04008821A (es) * 2002-03-15 2004-11-26 Btg Int Ltd Formulaciones de derivados de antraquinona.
WO2006031719A2 (en) * 2004-09-14 2006-03-23 Novacea, Inc. 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof
EP1853243A2 (en) * 2005-03-04 2007-11-14 Novacea, Inc. Treatment of hyperproliferative diseases with anthraquinones
US8420861B2 (en) * 2007-10-16 2013-04-16 D. Richard Ishmael Anti-tumor compounds derived from 1,4,5,8-tetrachloroanthraquinone
GB201005939D0 (en) 2010-04-09 2010-05-26 Biostatus Ltd Method of analysing a cell or other biological material containing nucleic acid
CN102397561B (zh) * 2011-09-26 2013-03-06 沈阳药科大学 米托蒽醌作为淋巴示踪剂的应用

Similar Documents

Publication Publication Date Title
JP2012504628A5 (enExample)
JP2015503625A5 (enExample)
JP2017509586A5 (enExample)
RU2018138828A (ru) Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами
JP2011519941A5 (enExample)
JP2018504379A5 (enExample)
CY1115571T1 (el) Νεες ενωσεις και μεθοδοι για θεραπεια
JP2014527974A5 (enExample)
JP2020506951A5 (enExample)
JP2014515406A5 (enExample)
HRP20110807T1 (hr) Supstituirani pirimidodiazepini korisni kao plk1 inhibitori
JP2008535902A5 (enExample)
RU2016126503A (ru) Аналоги кортистатина, их синтез и применения
JP2014528466A5 (enExample)
JP2018529739A5 (enExample)
JP2015520143A5 (enExample)
JP2013505946A5 (enExample)
JP2013542992A5 (enExample)
JP2015537020A5 (enExample)
JP2015529660A5 (enExample)
JP2014508811A5 (enExample)
JP2016506916A5 (enExample)
JP2009511490A5 (enExample)
JP2010540556A5 (enExample)
JP2012515776A5 (enExample)